99 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
Audit Fees
Audit-Related Fees
Tax Fees
All Other Fees
Total Fees
Audit Fees
For the years ended December 31, 2023 and December 31, 2022, Audit Fees … -Approval Policy generally provides that we will not engage our independent registered public accounting firm to render any audit, audit-related, tax
8-K
EX-99.1
58jhbuzw9mmq2
29 Feb 24
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:08am
8-K
EX-99.1
4ih3 8ieyaqvk
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-10.1
31y76ok juh63z
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
EX-99.1
q497bcf1ggb4ati
2 Nov 23
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:24am
8-K
EX-99.1
ns1r2k0p bw
3 Aug 23
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:11am
S-8
EX-5.1
wc96f4q2cjgdpdbupn
9 May 23
Registration of securities for employees
4:08pm
8-K
EX-99.1
dbbpb4fsv9b5x0s2 nh
9 May 23
Verona Pharma Reports First Quarter 2023 Financial Results and Provides Corporate Update
6:13am
8-K
EX-10.1
20u2rj8erbtd
1 May 23
Departure of Directors or Certain Officers
5:21pm
8-K
g9s3tjn uh1
20 Dec 22
Regulation FD Disclosure
6:02am
S-8
EX-5.1
ritvtz
15 Nov 22
Registration of securities for employees
4:13pm
8-K
EX-99.1
x9ixnnx 3v
9 Nov 22
Verona Pharma Reports Third Quarter 2022 Financial Results and Provides Corporate Update
6:35am